== Список литературы

[arabic]
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition // Cephalalgia. 2018. Vol. 38, № 1. P. 1–211.

. Ashina S. et al. Trigeminal neuralgia // Nat. Rev. Dis. Prim. 2024. Vol. 10, № 1. P. 39.

. Agostoni E., Frigerio R., Santoro P. Atypical facial pain: clinical considerations and differential diagnosis // Neurol. Sci. 2005. Vol. 26, № S2. P. s71–s74.

. Forssell H. et al. Differences and similarities between atypical facial pain and trigeminal neuropathic pain // Neurology. 2007. Vol. 69, № 14. P. 1451–1459.

. International Classification of Orofacial Pain, 1st edition (ICOP) // Cephalalgia. 2020. Vol. 40, № 2. P. 129–221.

. Jääskeläinen S.K. Pathophysiology of primary burning mouth syndrome // Clin. Neurophysiol. 2012. Vol. 123, № 1. P. 71–77.

. Scala A. et al. U pdate on B urning M outh S yndrome: O verview and P atient M anagement // Crit. Rev. Oral Biol. Med. 2003. Vol. 14, № 4. P. 275–291.

. Svensson P. et al. The many faces of persistent orofacial muscle pain. // J. oral facial pain headache. 2015. Vol. 29, № 2. P. 207–208.

. IASP. IASP taxonomy. https://www.iasp-pain.org/terminology?navItemNumber=576. 2024 [Electronic resource].

. Finnerup N.B., Kuner R., Jensen T.S. Neuropathic Pain: From Mechanisms to Treatment // Physiol. Rev. 2021. Vol. 101, № 1. P. 259–301.

. Под редакцией Е.И. Гусева А.Н.К.В.И.С. Неврология. Национальное руководство. ГЭОТАР-Медиа Москва, 2018.

. Volk G.F. et al. Initial severity of motor and non-motor disabilities in patients with facial palsy: an assessment using patient-reported outcome measures // Eur. Arch. Oto-Rhino-Laryngology. 2017. Vol. 274, № 1. P. 45–52.

. Zavaliy L.B. et al. Modern approaches to the treatment and rehabilitation of patients with facial neuropathy // Bull. Restor. Med. 2020. Vol. 96, № 2. P. 59–67.

. Парфёнов В.А., Яхно Н.Н., Зиновьева О.Е. Нервные болезни (в 2х томах). Москва: Медицинское информационное агентство, 2021.

. Zalyalova Z.A. Hemifacial spasm // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2020. Vol. 120, № 8. P. 140.

. Banik R., Miller N.R. Chronic Myokymia Limited to the Eyelid Is a Benign Condition // J. Neuro-Ophthalmology. 2004. Vol. 24, № 4. P. 290–292.

. Jafer Chardoub A.A. P.B.C. Eyelid Myokymia // StatPearls Publ. 2022.

. Keane J.R. Multiple Cranial Nerve Palsies // Arch. Neurol. 2005. Vol. 62, № 11. P. 1714.

. Maarbjerg S. et al. Significance of neurovascular contact in classical trigeminal neuralgia // Brain. 2015. Vol. 138, № 2. P. 311–319.

. Азимова Ю.Э., Сергеев А.В., Табеева Г.Р. Персистирующая идиопатическая лицевая боль // Российский журнал боли. 2011. Vol. 3. P. 3–7.

. Didier H. et al. Persistent idiopathic facial pain: multidisciplinary approach and assumption of comorbidity // Neurol. Sci. 2010. Vol. 31, № S1. P. 189–195.

. Hagelberg N. et al. Altered dopamine D2 receptor binding in atypical facial pain // Pain. 2003. Vol. 106, № 1. P. 43–48.

. Mense S. Muscle Pain – Mechanisms and Clinical Significance: In Reply // Dtsch. Arztebl. Int. 2008.

. Schmidt‐Wilcke T., Hierlmeier S., Leinisch E. Altered Regional Brain Morphology in Patients With Chronic Facial Pain // Headache J. Head Face Pain. 2010. Vol. 50, № 8. P. 1278–1285.

. Derbyshire S.W. et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. // J. Neurol. Neurosurg. Psychiatry. 1994. Vol. 57, № 10. P. 1166–1172.

. Пархоменко Е.В., Нартов С.Э., Карпов Д.Ю. Персистирующая идиопатическая лицевая боль: сложный путь к сложному диагнозу // Русский медицинский журнал. 2017. Vol. 24. P. 1738–1744.

. Bergdahl M., Bergdahl J. Burning mouth syndrome: prevalence and associated factors // J. Oral Pathol. Med. 1999. Vol. 28, № 8. P. 350–354.

. Боль. Практическое руководство / под ред. акад. РАН Н.Н. Яхно. Москва: МЕДпресс-информ, 2022. 416 p.

. Колвин Л.А., Фэллон М. Основы медицины боли: руководство / пер. с англ. под ред. А.Б. Данилова. Москва: ГЕОТАР-Медиа, 2015. 128 p.

. Laing K.J. et al. Immunobiology of Varicella-Zoster Virus Infection // J. Infect. Dis. 2018. Vol. 218, № suppl_2. P. S68–S74.

. Como C.N. et al. Varicella Zoster Virus Induces Differential Cell-Type Specific Responses in Human Corneal Epithelial Cells and Keratocytes // Investig. Opthalmology Vis. Sci. 2019. Vol. 60, № 2. P. 704.

. Lin D. et al. Serum interleukin-6 levels are increased in post-herpetic neuralgia: a single-center retrospective study // An. Bras. Dermatol. 2023. Vol. 98, № 2. P. 202–207.

. Marchenko N. V. et al. The potential of electromyography, diagnostic transcranial magnetic stimulation, and multiparametric magnetic resonance imaging in the combinatory assessment of facial nerve disorders: a literature review and clinical case series // Alm. Clin. Med. 2023. Vol. 51, № 3. P. 180–191.

. Zhang W. et al. The etiology of Bell’s palsy: a review // J. Neurol. 2020. Vol. 267, № 7. P. 1896–1905.

. Chang B. et al. Metagenomic next-generation sequencing of viruses, bacteria, and fungi in the epineurium of the facial nerve with Bell’s palsy patients // J. Neurovirol. 2020. Vol. 26, № 5. P. 727–733.

. Holland N.J., Bernstein J.M. Bell’s palsy. // BMJ Clin. Evid. 2014. Vol. 2014.

. Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. // Acta Otolaryngol. Suppl. 2002. № 549. P. 4–30.

. Finkensieper M., Volk G., Guntinas-Lichius O. Erkrankungen des Nervus facialis // Laryngo-Rhino-Otologie. 2012. Vol. 91, № 02. P. 121–142.

. Franzke P. et al. Weather, Weather Changes and the Risk of Bell’s Palsy: A Multicenter Case-Crossover Study // Neuroepidemiology. 2018. Vol. 51, № 3–4. P. 207–215.

. Hohman M.H., Hadlock T.A. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center // Laryngoscope. 2014. Vol. 124, № 7.

. Yeo S.-W. et al. Analysis of prognostic factors in Bell’s palsy and Ramsay Hunt syndrome // Auris Nasus Larynx. 2007. Vol. 34, № 2. P. 159–164.

. Chweya C.M. et al. For Whom the Bell’s Toll: Recurrent Facial Nerve Paralysis, A Retrospective Study and Systematic Review of the Literature // Otol. Neurotol. 2019. Vol. 40, № 4. P. 517–528.

. Zimmermann J. et al. Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study // J. Neurol. 2019. Vol. 266, № 10. P. 2488–2494.

. Tolisano A.M. et al. Determining Etiology of Facial Nerve Paralysis With MRI: Challenges in Malignancy Detection // Ann. Otol. Rhinol. Laryngol. 2019. Vol. 128, № 9. P. 862–868.

. Kim M.H., Park S.Y. Population-based study and a scoping review for the epidemiology and seasonality in and effect of weather on Bell’s palsy // Sci. Rep. 2021. Vol. 11, № 1. P. 16941.

. Lorch M., Teach S.J. Facial Nerve Palsy // Pediatr. Emerg. Care. 2010. Vol. 26, № 10. P. 763–769.

. Gretskikh K.V. et al. Early and late facial neuropathy after radiosurgery of vestibulocochlear schwannomas // Vestn. Nevrol. Psihiatr. i Nejrohir. (Bulletin Neurol. Psychiatry Neurosurgery). 2023. № 7. P. 525–535.

. Nau R., Christen H.-J., Eiffert H. Lyme Disease // Dtsch. Arztebl. Int. 2009.

. Shimanskiy V.N., Tanyashin S. V., Poshataev V.K. Surgical correction of cranial nerve vascular compression syndromes // Vopr. neirokhirurgii Im. N.N. Burdenko. 2017. Vol. 81, № 2. P. 96.

. Typical or Atypical Hemifacial Spasm // J. Neurosurg. 1998. Vol. 89, № 2.

. Berg T., Jonsson L. Corticosteroids and antivirals in Bell palsy // Nat. Rev. Neurol. 2013. Vol. 9, № 3. P. 128–129.

. Adour K.K. et al. The True Nature of Bell’s Palsy: Analysis af 1,000 Consecutive Patients // Laryngoscope. 1978. Vol. 88, № 5. P. 787–801.

. Chekhonatskaya K.I. et al. Synkinesis in patients with neuropathy of the facial nerve // Russ. Neurol. J. 2022. Vol. 27, № 5. P. 14–22.

. Shokri T. et al. Facial synkinesis: A distressing sequela of facial palsy // Ear, Nose Throat J. 2024. Vol. 103, № 6. P. NP382–NP391.

. Hammerschlag P.E. Facial reanimation with jump interpositional graft hypoglossal facial anastomosis and hypoglossal facial anastomosis: Evolution in management of facial paralysis // Laryngoscope. 1999. Vol. 109, № S90. P. 1–23.

. Mechrgui M., Kanani S. The Ophthalmic Side Effects of Topiramate: A Review // Cureus. 2022.

. Rissardo J.P., Medeiros Araujo de Matos U., Fornari Caprara A.L. Gabapentin-Associated Movement Disorders: A Literature Review // Medicines. 2023. Vol. 10, № 9. P. 52.

. Ghosh R. et al. Movement Disorders in Multiple Sclerosis: An Update // Tremor and Other Hyperkinetic Movements. 2022. Vol. 12, № 1. P. 14.

. Ito E., Sugita R., Saito R. Eyelid myokymia caused by a trigeminal schwannoma as determined by the trigeminal‐evoked blink reflex // Clin. Case Reports. 2023. Vol. 11, № 3.

. De Toledo I.P. et al. Prevalence of trigeminal neuralgia // J. Am. Dent. Assoc. 2016. Vol. 147, № 7. P. 570-576.e2.

. Feinmann C., Harris M., Cawley R. Psychogenic facial pain: presentation and treatment. // BMJ. 1984. Vol. 288, № 6415. P. 436–438.

. Wirz S. et al. Management of Chronic Orofacial Pain: A Survey of General Dentists in German University Hospitals // Pain Med. 2010. Vol. 11, № 3. P. 416–424.

. Labanca M. et al. Orofacial Pain and Dentistry Management: Guidelines for a More Comprehensive Evidence-Based Approach // Diagnostics. 2023. Vol. 13, № 17. P. 2854.

. Klompas M. et al. Herpes Zoster and Postherpetic Neuralgia Surveillance Using Structured Electronic Data // Mayo Clin. Proc. 2011. Vol. 86, № 12. P. 1146–1153.

. Fashner J., Bell A.L. Herpes zoster and postherpetic neuralgia: prevention and management. // Am. Fam. Physician. 2011. Vol. 83, № 12. P. 1432–1437.

. Шамалов Н.А. et al. Эпидемиология Заболеваний лицевого нерва в мегаполисе по данным единой медицинской системы города // Медицина и организация здравоохранения. 2024. Vol. 9, № 2. P. 60–69.

. Carmel Neiderman N.N. et al. Bell’s palsy and pregnancy: Incidence, comorbidities and complications. A meta‐analysis and systematic review of the literature // Clin. Otolaryngol. 2023. Vol. 48, № 4. P. 576–586.

. Koryagina A.D., Murashko A. V., Popova E. V. Peripheral neuropathy occurring during pregnancy (literature review) // V.F.Snegirev Arch. Obstet. Gynecol. 2023. Vol. 10, № 3. P. 187–193.

. Dong S.H. et al. Recurrent Bell’s palsy // Clin. Otolaryngol. 2019. Vol. 44, № 3. P. 305–312.

. Stornaiuolo A. et al. Multiple cranial neuropathy due to varicella zoster virus reactivation without vesicular rash: a challenging diagnosis // Neurol. Sci. 2023. Vol. 44, № 10. P. 3687–3689.

. Teggi R. et al. Cochleo-Vestibular Disorders in Herpes Zoster Oticus: A Literature Review and a Case of Bilateral Vestibular Hypofunction in Unilateral HZO // J. Clin. Med. 2023. Vol. 12, № 19. P. 6206.

. Евтушенко С.К., Гриштакова Е.Г. Ранняя диагностика и иммунокорригирующая терапия рецидивирующего неврита лицевого нерва как проявление синдрома Мелькерссона-Россолимо-Розенталя у взрослых и детей // Журнал невропатологии и психиатрии им. С.С. Корсакова. 1990. Vol. 12. P. 31–35.

. SIMONE M. et al. Intraparotid facial nerve schwannoma: two case reports and a review of the literature // Acta Otorhinolaryngol. Ital. 2018. Vol. 38, № 1. P. 73–77.

. Shimizu K. et al. Intraparotid facial nerve schwannoma: a report of five cases and an analysis of MR imaging results. // AJNR. Am. J. Neuroradiol. 2005. Vol. 26, № 6. P. 1328–1330.

. Auger R.G., Whisnant J.P. Hemifacial Spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984 // Arch. Neurol. 1990. Vol. 47, № 11. P. 1233–1234.

. Çelik M., Forta H., Vural Ç. The Development of Synkinesis after Facial Nerve Paralysis // Eur. Neurol. 2000. Vol. 43, № 3. P. 147–151.

. Salles A.G. et al. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years // Plast. Reconstr. Surg. 2015. Vol. 136, № 6. P. 1289–1298.

. Albahkaly S. et al. Reappraisal of glossopharyngeal neuralgia // Interdiscip. Neurosurg. 2018. Vol. 11. P. 34–36.

. Han A. et al. Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options // Heal. Psychol. Res. 2022. Vol. 10, № 5.

. Shah R.J., Padalia D. Glossopharyngeal Neuralgia. 2024.

. Burchiel K.J. A New Classification for Facial Pain // Neurosurgery. 2003. Vol. 53, № 5. P. 1164–1167.

. Zavaliy L.B. et al. Comprehensive approach to the diagnosis, treatment and rehabilitation of patients with facial nerve neuropathy at different periods of the disease // Russ. Neurol. J. 2022. Vol. 27, № 1. P. 69–79.

. Maarbjerg S. et al. Trigeminal Neuralgia – A Prospective Systematic Study of Clinical Characteristics in 158 Patients // Headache J. Head Face Pain. 2014. Vol. 54, № 10. P. 1574–1582.

. Nurmikko T.J. Altered Cutaneous Sensation in Trigeminal Neuralgia // Arch. Neurol. 1991. Vol. 48, № 5. P. 523–527.

. Mock D., Frydman W., Gordon A.S. Atypical facial pain: A retrospective study // Oral Surgery, Oral Med. Oral Pathol. 1985. Vol. 59, № 5. P. 472–474.

. Pfaffenrath V. et al. Atypical facial pain–application of the IHS criteria in a clinical sample // Cephalalgia. 1993. Vol. 13, № 12_suppl. P. 84–88.

. Lang E. et al. Persistent idiopathic facial pain exists independent of somatosensory input from the painful region: findings from quantitative sensory functions and somatotopy of the primary somatosensory cortex // Pain. 2005. Vol. 118, № 1. P. 80–91.

. Peck C.C. et al. Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders // J. Oral Rehabil. 2014. Vol. 41, № 1. P. 2–23.

. Truini A. et al. Pathophysiology of pain in postherpetic neuralgia: A clinical and neurophysiological study // Pain. 2008. Vol. 140, № 3. P. 405–410.

. Alvarez F.K. et al. Evaluation of the sensation in patients with trigeminal post‐herpetic neuralgia // J. Oral Pathol. Med. 2007. Vol. 36, № 6. P. 347–350.

. Chae S.A. et al. Association Between Clinical Symptoms, Electrodiagnostic Findings, Clinical Outcome, and Prodromal Symptoms in Patients With Bell’s Palsy // Ann. Otol. Rhinol. Laryngol. 2023. Vol. 132, № 1. P. 27–34.

. Lee S.-Y., Seong J., Kim Y.H. Clinical Implication of Facial Nerve Decompression in Complete Bell’s Palsy: A Systematic Review and Meta-Analysis // Clin. Exp. Otorhinolaryngol. 2019. Vol. 12, № 4. P. 348–359.

. Rimkevichus A.A.R. et al. First experience with botulinum toxin type A in central prosoparesis // Pharmateca. 2022. Vol. 3_2022. P. 83–90.

. Zavaliy L.B. et al. The neuropathy of marginal mandibular branch of the facial nerve // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2022. Vol. 122, № 11. P. 143.

. RALLI G., MAGLIULO G., GAGLIARDI M. Bell’s palsy and stapedial reflex // Clin. Otolaryngol. 1986. Vol. 11, № 4. P. 261–265.

. Rosen G., Sellars S.L. The stapedius reflex in idiopathic facial palsy // J. Laryngol. Otol. 1980. Vol. 94, № 9. P. 1017–1020.

. Саксонова Е.В., Орлова О.Р. Болевой синдром при параличе Белла // Лечение заболеваний нервной системы. 2014. Vol. 3, № 15. P. 36–40.

. Orlova O.R. et al. The use of botulinum toxin type a in the acute phase of facial nerve injury after neurosurgical surgery // Vopr. neirokhirurgii Im. N.N. Burdenko. 2014. Vol. 78, № 6. P. 50.

. Zavaliy L.B. et al. Rehabilitation of patients with facial nerve neuropathy in cases of increased muscle tone on the healthy side of the face // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2024. Vol. 124, № 2. P. 116.

. Volk G.F. et al. Quantitative ultrasonography of facial muscles in patients with chronic facial palsy // Muscle Nerve. 2014. Vol. 50, № 3. P. 358–365.

. Zavaliy L.B. et al. Rehabilitation of patients with complications of facial nerve neuropathy // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2023. Vol. 123, № 11. P. 90.

. Завалий Л.Б. et al. Диагностика, лечение и реабилитация пациентов с паралитическим лагофтальмом // Нервные болезни. 2023. Vol. 3. P. 36–45.

. Гусев Е.И. Неврология и нейрохирургия. В 2 т. Т. 1. Неврология : учебник / Е. И. Гусев, А. Н. Коновалов, В. И. Скворцова; под ред. А. Н. Коновалова, А. В. Козлова. - 4-е изд. , доп. . Москва: ГЭОТАР-Медиа, 2015. 640 p.

. Remick R.A., Blasberg B. Psychiatric aspects of atypical facial pain. // J. Can. Dent. Assoc. 1985. Vol. 51, № 12. P. 913–916.

. Essentials of Pain Medicine. Elsevier, 2011.

. Heckmann J.G. et al. The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell’s Palsy) // Dtsch. Arztebl. Int. 2019.

. Singh A., Deshmukh P. Bell’s Palsy: A Review // Cureus. 2022.

. Weiss A.L., Ehrhardt K.P., Tolba R. Atypical Facial Pain: a Comprehensive, Evidence-Based Review // Curr. Pain Headache Rep. 2017. Vol. 21, № 2. P. 8.

. Ponte C. et al. 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis // Arthritis Rheumatol. 2022. Vol. 74, № 12. P. 1881–1889.

. Yanagihara N. Incidence of Bell’s Palsy // Ann. Otol. Rhinol. Laryngol. 1988. Vol. 97, № 6_suppl3. P. 3–4.

. DE DIEGO J.I. et al. Seasonal Patterns of Idiopathic Facial Paralysis: A 16‐Year Study // Otolaryngol. Neck Surg. 1999. Vol. 120, № 2. P. 269–271.

. Petrikov S.S. et al. Routing, diagnosis and treatment of adult patients with facial nerve neuropathy in the metropolis // Russ. Neurol. J. 2023. Vol. 28, № 5. P. 40–51.

. Zavaliy L.B. et al. Diagnosis of patients with facial neuropathy by practicing neurologists: online survey // Russ. Neurol. J. 2023. Vol. 28, № 2. P. 15–24.

. Cabrol C. et al. Sunnybrook Facial Grading System: Intra-rater and Inter-rater Variabilities // Otol. Neurotol. 2021. Vol. 42, № 7. P. 1089–1094.

. Fieux M. et al. French Society of ENT (SFORL) guidelines. Management of acute Bell’s palsy // Eur. Ann. Otorhinolaryngol. Head Neck Dis. 2020. Vol. 137, № 6. P. 483–488.

. House J.W., Brackmann D.E. Facial Nerve Grading System // Otolaryngol. Neck Surg. 1985. Vol. 93, № 2. P. 146–147.

. Hu W.-L., Ross B., Nedzelski J. Reliability of the Sunnybrook Facial Grading System by Novice Users // J. Otolaryngol. 2001. Vol. 30, № 04. P. 208.

. MAT LAZIM N. et al. Comparison of 3 Grading Systems (House-Brackmann, Sunnybrook, Sydney) for the Assessment of Facial Nerve Paralysis and Prediction of Neural Recovery // Medeni. Med. J. 2023. Vol. 38, № 2. P. 111–119.

. Завалий Л.Б. et al. Современные подходы к диагностике и лечению лагофтальма при невропатии лицевого нерва // Нервные болезни. 2023. Vol. 1. P. 81–88.

. Baugh R.F. et al. Clinical Practice Guideline: Bell’s Palsy // Otolaryngol. Neck Surg. 2013. Vol. 149, № S3.

. de Almeida J.R. et al. Management of Bell palsy: clinical practice guideline // Can. Med. Assoc. J. 2014. Vol. 186, № 12. P. 917–922.

. Castiglione M. et al. Immediate disappearance of hemifacial spasm after partial removal of ponto-medullary junction anaplastic astrocytoma: case report // Neurosurg. Rev. 2015. Vol. 38, № 2. P. 385–390.

. Lee S.-U. et al. Lower brainstem melanocytoma masquerading as vestibular paroxysmia // J. Neurol. 2018. Vol. 265, № 5. P. 1222–1225.

. Martin E.J. et al. Hemifacial Spasm Secondary to Parotid Pleomorphic Adenoma With Stylomastoid Foramen Extension // Otol. Neurotol. 2017. Vol. 38, № 1. P. 129–132.

. Basker R.M., Sturdee D.W., Davenport J.C. Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes // Br. Dent. J. 1978. Vol. 145, № 1. P. 9–16.

. CARRINGTON J., GETTER L., BROWN R.S. Diabetic neuropathy masquerading as glossodynia // J. Am. Dent. Assoc. 2001. Vol. 132, № 11. P. 1549–1551.

. Faccini J.M. Oral manifestations of vitamin B12 deficiency // Br. J. Oral Surg. 1968. Vol. 6, № 2. P. 137–140.

. Kanaparthi Alekhya, Srikar Muppirala. Oral Manifestations of Vitamin B12 (Cobalamin) Deficiency: A Review // Int. Healthc. Res. J. 2019. Vol. 3, № 1. P. 9–15.

. Fan H.-R. et al. Correction: Early Diagnosis of Herpes Zoster Neuralgia: A Narrative Review // Pain Ther. 2024. Vol. 13, № 5. P. 1323–1323.

. Kilgore P.E. et al. Varicella in Americans from NHANES III: Implications for control through routine immunization // J. Med. Virol. 2003. Vol. 70, № S1. P. S111–S118.

. Oya R. et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Hematologic Markers of Bell’s Palsy: A Meta-analysis // Otol. Neurotol. 2019. Vol. 40, № 5. P. 681–687.

. Runesson B., Jonsson A., Lindeman E. [Diethylene glycol poisoning - the first known Swedish case]. // Lakartidningen. 2021. Vol. 118.

. Simsek M., Bilici M., Tekin S. Creatinine kinase elevation and peripheral neuropathy during nivolumab treatment of a patient with metastatic renal cell carcinoma // Indian J. Cancer. 2018. Vol. 55, № 4. P. 413.

. Shekar V. et al. Facial nerve paralysis: A case report of rare complication in uncontrolled diabetic patient with mucormycosis // J. Nat. Sci. Biol. Med. 2015. Vol. 6, № 1. P. 226.

. Liu M. et al. Bulbar Paralysis and Facial Paralysis due to Metastatic Hepatocellular Carcinoma // Medicine (Baltimore). 2016. Vol. 95, № 4. P. e2632.

. Ramirez-Sanchez C. et al. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient // J. Neurovirol. 2021. Vol. 27, № 5. P. 797–801.

. Hwang Y.S. et al. Two cases of Ramsay-Hunt syndrome following varicella zoster viral meningitis in young immunocompetent men: case reports // BMC Neurol. 2023. Vol. 23, № 1. P. 43.

. Hepprich M. et al. Hypothyroidism manifesting as multiple cranial neuropathies: a case report // J. Med. Case Rep. 2019. Vol. 13, № 1. P.
180.

. Saito O. et al. Diagnosis and Treatment for Bell’s Palsy Associated with Diabetes Mellitus // Acta Otolaryngol. 1994. Vol. 114, № sup511. P.
153–155.

. Sathirapanya P. et al. Peripheral facial paralysis associated with HIV infection: A case series and literature review // Clin. Neurol. Neurosurg. 2018. Vol. 172. P. 124–129.

. Cooper L. et al. Lyme disease and Bell’s palsy: an epidemiological study of diagnosis and risk in England // Br. J. Gen. Pract. 2017. Vol. 67, № 658. P. e329–e335.

. Gordillo-Pérez G. et al. Serological Evidence of Borrelia Burgdorferi Infection in Mexican Patients with Facial Palsy. // Rev. Invest. Clin. 2017. Vol. 69, № 6. P. 344–348.

. Wallménius K., Påhlson C., Nilsson K. Retrospective serological study of Rickettsia spp. and Borrelia spp. antibodies in patients with peripheral facial nerve palsy // Infect. Ecol. Epidemiol. 2021. Vol. 11, № 1.

. Stahl A. et al. Association Between Thyroid-Stimulating Hormone Level and Bell’s Palsy // Otol. Neurotol. 2023. Vol. 44, № 7. P. 730–736.

. MAJIGSUREN M. et al. Comparison of Brain Tumor Contrast-enhancement on T&lt;sub&gt;1&lt;/sub&gt;-CUBE and 3D-SPGR Images // Magn. Reson. Med. Sci. 2016. Vol. 15, № 1. P. 34–40.

. Liang C. et al. Different MRI-based methods for the diagnosis of neurovascular compression in trigeminal neuralgia or hemifacial spasm: A network meta-analysis // J. Clin. Neurosci. 2023. Vol. 108. P. 19–24.

. Koch M. et al. Ultrasound in Inflammatory and Obstructive Salivary Gland Diseases: Own Experiences and a Review of the Literature // J. Clin. Med. 2021. Vol. 10, № 16. P. 3547.

. Öztunç H. et al. Cone-beam computed tomographic evaluation of styloid process: a retrospective study of 208 patients with orofacial pain // Head Face Med. 2014. Vol. 10, № 1. P. 5.

. Choi E. et al. Artificial intelligence in detecting temporomandibular joint osteoarthritis on orthopantomogram // Sci. Rep. 2021. Vol. 11, № 1. P. 10246.

. Schmitter M. et al. Validity of temporomandibular disorder examination procedures for assessment of temporomandibular joint status // Am. J. Orthod. Dentofac. Orthop. 2008. Vol. 133, № 6. P. 796–803.

. Cornelissen P. et al. 3. Persistent Idiopathic Facial Pain // Pain Pract. 2009. Vol. 9, № 6. P. 443–448.

. Nóbrega J.C.M. et al. Diferential diagnosis in atypical facial pain: a clinical study // Arq. Neuropsiquiatr. 2007. Vol. 65, № 2A. P. 256–261.

. MANFREDINI D. et al. Surface electromyography of jaw muscles and kinesiographic recordings: diagnostic accuracy for myofascial pain // J. Oral Rehabil. 2011. Vol. 38, № 11. P. 791–799.

. Paterson A.J. et al. Burning mouth syndrome: the relationship between the HAD scale and parafunctional habits // J. Oral Pathol. Med. 1995. Vol. 24, № 7. P. 289–292.

. Gunes A. et al. Trigeminal nerve and pathologies in magnetic resonance imaging – a pictorial review // Polish J. Radiol. 2018. Vol. 83. P. 289–296.

. Zhao Y.-X. et al. Trigeminal somatosensory-evoked potential // Medicine (Baltimore). 2017. Vol. 96, № 3. P. e5872.

. Whyte A., Matias M.A.T.J. Imaging of orofacial pain // J. Oral Pathol. Med. 2020. Vol. 49, № 6. P. 490–498.

. Edvardsson B., Persson S. Cluster Headache and Parietal Glioblastoma Multiforme // Neurologist. 2012. Vol. 18, № 4. P. 206–207.

. Levy M.J., Robertson I., Howlett T.A. Cluster Headache Secondary to Macroprolactinoma with Ipsilateral Cavernous Sinus Invasion // Case Rep. Neurol. Med. 2012. Vol. 2012. P. 1–3.

. Porta‐Etessam J. et al. Clusterlike Headache as First Manifestation of a Prolactinoma // Headache J. Head Face Pain. 2001. Vol. 41, № 7. P. 723–725.

. Chitsantikul P., Becker W.J. SUNCT, SUNA and pituitary tumors: Clinical characteristics and treatment // Cephalalgia. 2013. Vol. 33, № 3. P.
160–170.

. Jiménez Caballero P.E., Portilla Cuenca J.C., Casado Naranjo I. Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) secondary to epidermoid cyst in the right cerebellopontine angle successfully treated with surgery // J. Headache Pain. 2011. Vol. 12, № 3. P. 385–387.

. Jacob S., Rajabally Y. Short-Lasting Unilateral Neuralgiform Headache with Cranial Autonomic Symptoms (SUNA) Following Vertebral Artery Dissection // Cephalalgia. 2007. Vol. 27, № 3. P. 283–285.

. Murphy T.P., Teller D.C. Magnetic Resonance Imaging of the Facial Nerve During Bell’s Palsy // Otolaryngol. Neck Surg. 1991. Vol. 105, № 5. P. 667–674.

. Saatçi I. et al. MRI of the facial nerve in idiopathic facial palsy // Eur. Radiol. 1996. Vol. 6, № 5. P. 631–636.

. Kinoshita T. et al. Facial Nerve Palsy: Evaluation by Contrast-enhanced MR Imaging // Clin. Radiol. 2001. Vol. 56, № 11. P. 926–932.

. Приказ Министерства здравоохранения Российской Федерации от 15 ноября 2012 г. № 928н “Об утверждении Порядка оказания медицинской помощи больным с острыми нарушениями мозгового кровообращения.”

. Breadon G.E., Cody D.T.R., Weilandz L.H. Facial palsy: Unusual Etiology // Laryngoscope. 1977. Vol. 87, № 1. P. 26–34.

. Klimkin A. V., Voitenkov V.B., Skripchenko N. V. Neurosonography of the facial nerve in children with idiopathic neuropathy of facial nerve // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2017. Vol. 117, № 12. P. 52.

. Petrikov S.S. et al. Neuroimaging in facial nerve neuropathy // Russ. Neurol. J. 2023. Vol. 28, № 4. P. 24–34.

. Guenette J.P. et al. MR Imaging of the Extracranial Facial Nerve with the CISS Sequence // Am. J. Neuroradiol. 2019.

. Lee M.-K. et al. Identification of the intraparotid facial nerve on MRI: a systematic review and meta-analysis // Eur. Radiol. 2021. Vol. 31, № 2. P. 629–639.

. Dreizin D. et al. CT of Skull Base Fractures: Classification Systems, Complications, and Management // RadioGraphics. 2021. Vol. 41, № 3. P. 762–782.

. Rajati M. et al. Accuracy of high-resolution computed tomography in locating facial nerve injury sites in temporal bone trauma // Eur. Arch. Oto-Rhino-Laryngology. 2014. Vol. 271, № 8. P. 2185–2189.

. Stewart K.E., Bannon R., Bannister M. Benign parotid mass and facial palsy: systematic review. // Ann. R. Coll. Surg. Engl. 2021. Vol. 103, №
1. P. 47–52.

. Kim J.K. et al. Ultrasonographic Localization of Parotid Gland Tumor Relative to the Facial Nerve Using Stensen’s Duct Criterion // J. Oral Maxillofac. Surg. 2023. Vol. 81, № 8. P. 1055–1061.

. Завалий Л.Б. et al. Невропатия лицевого нерва: оперировать или нет? // Нервные болезни. 2023. Vol. 4. P. 76–84.

. Khedr E.M. et al. Prognostic role of neurophysiological testing 3–7 days after onset of acute unilateral Bell’s palsy // Neurophysiol. Clin. 2018. Vol. 48, № 2. P. 111–117.

. OLSEN P.Z. PREDICTION OF RECOVERY IN BELL’S PALSY // Acta Neurol. Scand. 2009. Vol. 52. P. 1–119.

. Савицкая Н.Г. et al. Электромиография: прогноз и оценка эффективности терапии при параличе Белла // Неврология, нейропсихиатрия, психосоматика. 2011. Vol. 3. P. 60–64.

. Савицкая Н.Г. et al. Возможности электромиографии в прогнозировании восстановления при идиопатической нейропатии лицевого нерва // Нервно-мышечные болезни. 2012. Vol. 4. P. 36–42.

. Kim J. et al. Surgical Reconsideration of Traumatic Facial Paralysis // Otol. Neurotol. 2022. Vol. 43, № 8. P. 968–972.

. Gantz B.J. et al. Surgical Management of Bell’s Palsy // Laryngoscope. 1999. Vol. 109, № 8. P. 1177–1188.

. Завалий Л.Б. et al. Клинический случай восстановления функции мимических мышц у пациентки с травматическим поражением краевой нижнечелюстной ветви лицевого нерва при плегии мышцы, опускающей нижнюю губу // Нервные болезни. 2022. Vol. 3. P. 52–55.

. Chekhonatskaya K.I. et al. Clinical Case of Facial Muscles Function Recovery in a Patient With Idiopathic Lesions of the Facial Nerve With Unfavorable Myographic Predictors // Russ. Sklifosovsky J. “Emergency Med. Care.” 2021. Vol. 10, № 1. P. 216–223.

. Fischbein N.J. et al. MR imaging in two cases of subacute denervation change in the muscles of facial expression. // AJNR. Am. J. Neuroradiol. 2001. Vol. 22, № 5. P. 880–884.

. Kaylie D.M., Wax M.K., Weissman J.L. Preoperative facial muscle imaging predicts final facial function after facial nerve grafting. // AJNR. Am. J. Neuroradiol. 2003. Vol. 24, № 3. P. 326–330.

. Farrugia M.E. et al. Magnetic resonance imaging of facial muscles // Clin. Radiol. 2007. Vol. 62, № 11. P. 1078–1086.

. Hermier M. Imaging of hemifacial spasm // Neurochirurgie. 2018. Vol. 64, № 2. P. 117–123.

. Garcia M. et al. High-Resolution 3D-Constructive Interference in Steady-State MR Imaging and 3D Time-of-Flight MR Angiography in Neurovascular Compression: A Comparison between 3T and 1.5T // Am. J. Neuroradiol. 2012. Vol. 33, № 7. P. 1251–1256.

. Zakrzewska J.M. Diagnosis and Differential Diagnosis of Trigeminal Neuralgia // Clin. J. Pain. 2002. Vol. 18, № 1. P. 14–21.

. Hegarty A.M., Zakrzewska J.M. Differential diagnosis for orofacial pain, including sinusitis, tmd, trigeminal neuralgia // Dent. Update. 2011. Vol. 38, № 6. P. 396–408.

. Melek L.N., Devine M., Renton T. The psychosocial impact of orofacial pain in trigeminal neuralgia patients: a systematic review // Int. J. Oral Maxillofac. Surg. 2018. Vol. 47, № 7. P. 869–878.

. Zakrzewska J.M., Patsalos P.N. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia // Pain. 2002. Vol. 95, № 3. P. 259–266.

. Spatz A.L., Zakrzewska J.M., Kay E.J. Decision analysis of medical and surgical treatments for trigeminal neuralgia: How patient evaluations of benefits and risks affect the utility of treatment decisions // Pain. 2007. Vol. 131, № 3. P. 302–310.

. Di Stefano G., Maarbjerg S., Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options // J. Headache Pain. 2019. Vol. 20, № 1. P. 20.

. Ferraro D. et al. Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study // Mult. Scler. Relat. Disord. 2020. Vol. 37. P. 101461.

. Cibirka R.M., Nelson S.K., Lefebvre C.A. Burning mouth syndrome: A review of etiologies // J. Prosthet. Dent. 1997. Vol. 78, № 1. P. 93–97.

. Giannakopoulos N.N. et al. Anxiety and depression in patients with chronic temporomandibular pain and in controls // J. Dent. 2010. Vol. 38, № 5. P. 369–376.

. Velly A.M. et al. The effect of catastrophizing and depression on chronic pain – a prospective cohort study of temporomandibular muscle and joint pain disorders // Pain. 2011. Vol. 152, № 10. P. 2377–2383.

. Dahan H. et al. Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration // J. Headache Pain. 2015. Vol. 16, № 1. P. 47.

. National Guideline Centre (UK). Evidence review for psychological therapy for chronic primary pain: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain: Evidence review F. London: National Institute for Health and Care Excellence (NICE); 2021 Apr. (NICE Guideline, No. 193.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK569983/ [Electronic resource].

. Werner R.N. et al. European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment // J. Eur. Acad. Dermatology Venereol. 2017. Vol. 31, № 1. P. 20–29.

. Gross G.E. et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia // JDDG J. der Dtsch. Dermatologischen Gesellschaft. 2020. Vol. 18, № 1. P. 55–78.

. Renton T. Dental (Odontogenic) Pain. // Rev. pain. 2011. Vol. 5, № 1. P. 2–7.

. World Dental Federation F. Odontogenic Pain Management: Adopted by the FDI General Assembly: August 2017, Madrid, Spain. // Int. Dent. J. 2018. Vol. 68, № 1. P. 20–21.

. Zavaliy L.B. et al. Screening diagnostics of emotional distress in patients with facial neuropathy // Russ. Neurol. J. 2022. Vol. 27, № 3. P. 47–53.

. Rakhmanina A.A. et al. Psychological Factors of Emotional Disadaptation in Patients with Facial Movement Disorders // Clin. Psychol. Spec. Educ. 2022. Vol. 11, № 4. P. 159–178.

. Casazza G.C., Schwartz S.R., Gurgel R.K. Systematic Review of Facial Nerve Outcomes After Middle Fossa Decompression and Transmastoid Decompression for Bell’s Palsy With Complete Facial Paralysis // Otol. Neurotol. 2018. Vol. 39, № 10. P. 1311–1318.

. Wang P. et al. Effects of Surgical Timing of Facial Nerve Decompression for Patients With Severe Bell’s Palsy. // Altern. Ther. Health Med. 2023. Vol. 29, № 2. P. 70–75.

. Wang P. et al. [Effect analysis of facial nerve decompression surgery in the treatment of Bell’s palsy and Hunt syndrome]. // Lin Chung. Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024. Vol. 38, № 5. P. 391–394.

. Berania I. et al. Delayed facial nerve decompression for severe refractory cases of Bell’s palsy: A 25-year experience // J. Otolaryngol. - Head Neck Surg. 2018. Vol. 47, № 1.

. Han J.H. et al. Facial reanimation using hypoglossal-facial nerve anastomosis after schwannoma removal // Acta Otolaryngol. 2017. Vol. 137, № 1. P. 99–105.

. Socolovsky M. et al. Bell′s palsy and partial hypoglossal to facial nerve transfer: Case presentation and literature review // Surg. Neurol. Int. 2012. Vol. 3, № 1. P. 46.

. Kim L., Byrne P.J. Controversies in Contemporary Facial Reanimation // Facial Plast. Surg. Clin. North Am. 2016. Vol. 24, № 3. P. 275–297.

. Harris B.N., Tollefson T.T. Facial reanimation // Curr. Opin. Otolaryngol. Head Neck Surg. 2015. Vol. 23, № 5. P. 399–406.

. Faria J.C.M. et al. Muscle Transplants for Facial Reanimation // Ann. Plast. Surg. 2009. Vol. 63, № 2. P. 148–152.

. Guntinas-Lichius O., Genther D.J., Byrne P.J. Facial Reconstruction and Rehabilitation. 2016. P. 120–131.

. Azizzadeh B., Pettijohn K.J. The Gracilis Free Flap // Facial Plast. Surg. Clin. North Am. 2016. Vol. 24, № 1. P. 47–60.

. Ueda K. et al. Combination of Hypoglossal-Facial Nerve Jump Graft by End-to-Side Neurorrhaphy and Cross-Face Nerve Graft for the Treatment of Facial Paralysis // J. Reconstr. Microsurg. 2007. Vol. 23, № 4. P. 181–187.

. Biglioli F. et al. Masseteric–facial nerve neurorrhaphy: results of a case series // J. Neurosurg. 2017. Vol. 126, № 1. P. 312–318.

. Cotrufo S. et al. Topographic anatomy of the nerve to masseter: An anatomical and clinical study // J. Plast. Reconstr. Aesthetic Surg. 2011. Vol. 64, № 11. P. 1424–1429.

. Fournier H.-D. et al. An anatomical study of the motor distribution of the mandibular nerve for a masseteric-facial anastomosis to restore facial function // Surg. Radiol. Anat. 1997. Vol. 19, № 4. P. 241–244.

. Faria J.C.M., Scopel G.P., Ferreira M.C. Facial Reanimation With Masseteric Nerve // Ann. Plast. Surg. 2010. Vol. 64, № 1. P. 31–34.

. Coombs C.J. et al. Masseteric-facial nerve coaptation – an alternative technique for facial nerve reinnervation // J. Plast. Reconstr. Aesthetic Surg. 2009. Vol. 62, № 12. P. 1580–1588.

. Ahuja R.B., Chatterjee P. Contemporary Solutions for the Treatment of Facial Nerve Paralysis // Plast. Reconstr. Surg. 2016. Vol. 137, № 2. P. 482e-483e.

. Owusu Boahene K.D. Temporalis Muscle Tendon Unit Transfer for Smile Restoration After Facial Paralysis // Facial Plast. Surg. Clin. North Am. 2016. Vol. 24, № 1. P. 37–45.

. Namavarian A. et al. Selective Neurectomy for Postfacial Paralysis Synkinesis: A Systematic Review // Facial Plast. Surg. 2024.

. Azizzadeh B. et al. Modified Selective Neurectomy for the Treatment of Post–Facial Paralysis Synkinesis // Plast. Reconstr. Surg. 2019. Vol. 143, № 5. P. 1483–1496.

. Azizzadeh B., Frisenda J.L. Surgical Management of Postparalysis Facial Palsy and Synkinesis // Otolaryngol. Clin. North Am. 2018. Vol. 51, № 6. P. 1169–1178.

. Holste K. et al. Spasm Freedom Following Microvascular Decompression for Hemifacial Spasm: Systematic Review and Meta-Analysis // World Neurosurg. 2020. Vol. 139. P. e383–e390.

. Wolff Fernandes F., Krauss J.K. Microvascular Decompression: A Bibliometric Analysis of the 100 Most Cited Articles // World Neurosurg. 2022. Vol. 164. P. e67–e81.

. Rao S., Rao S.J., Raghani M. Glossopharyngeal Neuralgia, An Usually Overlooked Diagnosis: A Prospective Single Center Observation Study // Indian J. Otolaryngol. Head Neck Surg. 2022. Vol. 74, № S2. P. 1955–1960.

. Revuelta-Gutiérrez R. et al. Glossopharyngeal and vagoglossopharyngeal neuralgia: Long-term surgical outcomes in a single institution // Surg. Neurol. Int. 2023. Vol. 14. P. 267.

. Bendtsen L. et al. European Academy of Neurology guideline on trigeminal neuralgia // Eur. J. Neurol. 2019. Vol. 26, № 6. P. 831–849.

. Chong M.S., Bahra A., Zakrzewska J.M. Guidelines for the management of trigeminal neuralgia // Cleve. Clin. J. Med. 2023. Vol. 90, № 6. P. 355–362.

. Неврология. Фармакотерапия без ошибок. Руководство для врачей / под ред. А.А. Скоромца, А.В. Амелина. Москва: Е-ното, 2019. 608 p.

. Royal College of Surgeons of England. Guidelines for the management of trigeminal neuralgia. 2021.

. Hu X. et al. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia // Clin. J. Pain. 2024. Vol. 40, № 6. P. 383–392.

. Morra M.E. et al. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials // J. Headache Pain. 2016. Vol. 17, № 1. P. 63.

. Zhang H. et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial // J. Headache Pain. 2014. Vol. 15, № 1. P. 65.

. Herrero Babiloni A. et al. Non-invasive brain stimulation in chronic orofacial pain: a systematic review // J. Pain Res. 2018. Vol. Volume 11. P. 1445–1457.

. Säisänen L. et al. Efficacy and tolerability in patients with chronic facial pain of two consecutive treatment periods of rTMS applied over the facial motor cortex, using protocols differing in stimulation frequency, duration, and train pattern // Neurophysiol. Clin. 2022. Vol. 52, № 2. P. 95–108.

. Moore D. et al. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia // Br. J. Anaesth. 2019. Vol. 123, № 2. P. e385–e396.

. Zúñiga C. et al. Acute Treatment of Trigeminal Neuralgia With Onabotulinum Toxin A // Clin. Neuropharmacol. 2013. Vol. 36, № 5. P. 146–150.

. Hsu C.-C. et al. Rapid Management of Trigeminal Neuralgia and Comorbid Major Depressive Disorder With Duloxetine // Ann. Pharmacother. 2014. Vol. 48, № 8. P. 1090–1092.

. Carasso R.L., Yehuda S., Streifler M. Clomipramine and Amitriptyline in the Treatment of Severe Pain // Int. J. Neurosci. 1979. Vol. 9, № 3. P. 191–194.

. Gallagher H.C. et al. Venlafaxine for neuropathic pain in adults // Cochrane Database Syst. Rev. 2015. Vol. 2017, № 6.

. Lunn M.P., Hughes R.A., Wiffen P.J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia // Cochrane Database Syst. Rev. 2014. Vol. 2015, № 10.

. Birkinshaw H. et al. Antidepressants for pain management in adults with chronic pain: a network meta-analysis // Cochrane Database Syst. Rev. 2023. Vol. 2023, № 5.

. Anand K.S. et al. Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia. // J. Indian Med. Assoc. 2011. Vol. 109, № 4. P. 264–266.

. Латышева Н.В., Филатова Е.Г. Применение антидепрессантов в общей клинической практике.: Учебное пособие. Москва, 2022.

. Aggarwal V.R. et al. Psychosocial interventions for the management of chronic orofacial pain // Cochrane Database of Systematic Reviews / ed. Aggarwal V.R. Chichester, UK: John Wiley & Sons, Ltd, 2011.

. Aggarwal V.R. et al. Psychosocial interventions for the management of chronic orofacial pain // Cochrane Database Syst. Rev. 2015. Vol. 2015, № 12.

. Otis J.D. Managing Chronic Pain: Therapist Guide. Oxford University Press, 2007.

. Khan A. et al. Management of myofascial pain dysfunction syndrome with meditation and yoga: Healing through natural therapy // Natl. J. Maxillofac. Surg. 2018. Vol. 9, № 2. P. 155.

. Day M.A. et al. Mindfulness-based Cognitive Therapy for the Treatment of Headache Pain // Clin. J. Pain. 2014. Vol. 30, № 2. P. 152–161.

. Ren H., Shen Y., Luo F. Treatment of Supraorbital Neuralgia Using Ultrasound-Guided Radiofrequency Thermocoagulation of the Supraorbital Nerve: A Retrospective Study // J. Pain Res. 2020. Vol. Volume 13. P. 251–259.

. Xie K. et al. Effects of Supraorbital Foramen Variations on the Treatment Efficacy of Radiofrequency Therapy for V1 Trigeminal Neuralgia: A Retrospective Study // Pain Res. Manag. 2020. Vol. 2020. P. 1–6.

. Luo F. et al. High Voltage Pulsed Radiofrequency for the Treatment of Refractory Neuralgia of the Infraorbital Nerve: A Prospective Double-Blinded Randomized Controlled Study. // Pain Physician. 2017. Vol. 20, № 4. P. 271–279.

. Jia Y. et al. The Effectiveness and Safety of 42°C Pulsed Radiofrequency Combined with 60°C Continuous Radiofrequency for Refractory Infraorbital Neuralgia: A Prospective Study. // Pain Physician. 2019. Vol. 22, № 3. P. E171–E179.

. Sun Z. et al. Effectiveness and Safety of Radiofrequency Thermocoagulation Treatment Guided by Computed Tomography for Infraorbital Neuralgia Following Failed Conservative Treatment: A Retrospective Study // J. Pain Res. 2023. Vol. Volume 16. P. 1005–1015.

. M M. et al. A Randomized Controlled Trial Comparing the Effect of Two-Time Durations of Balloon Compression During Percutaneous Balloon Compression in Resistant Trigeminal Neuralgia. // Pain Physician. 2024. Vol. 27, № 1. P. 21–26.

. Jia Y. et al. Effectiveness and safety of high-voltage pulsed radiofrequency to treat patients with primary trigeminal neuralgia: a multicenter, randomized, double-blind, controlled study // J. Headache Pain. 2023. Vol. 24, № 1. P. 91.

. Howng S.L., Chang D.S. Partial sensory rhizotomy as an alternative treatment of trigeminal neuralgia. // Kaohsiung J. Med. Sci. 1998. Vol. 14, № 8. P. 492–497.

. Díaz-Molina J. et al. Partial sensory rhizotomy in recurrent trigeminal neuralgia. Our experience and literature review // Neurocir. (English Ed. 2024.

. Arias M.J. Percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia // J. Neurosurg. 1986. Vol. 65, № 1. P. 32–36.

. Harries A.M., Mitchell R.D. Percutaneous glycerol rhizotomy for trigeminal neuralgia: safety and efficacy of repeat procedures // Br. J. Neurosurg. 2011. Vol. 25, № 2. P. 268–272.

. Chen L. et al. Endoscopic microvascular decompression versus microscopic microvascular decompression for trigeminal neuralgia: A systematic review and meta-analysis // J. Clin. Neurosci. 2023. Vol. 117. P. 73–78.

. Hannan C., Shoakazemi A., Quigley G. Microvascular Decompression for Trigeminal Neuralgia: A regional unit’s experience. // Ulster Med. J. 2018. Vol. 87, № 1. P. 30–33.

. Andersen A.S.S. et al. Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients. // J. Headache Pain. 2022. Vol. 23, № 1. P. 145.

. Uhl C. et al. Transposition versus interposition method in microvascular decompression for trigeminal neuralgia: midterm analysis of both techniques in a single-center study // J. Neurosurg. 2024. P. 1–8.

. Mansano A.M. et al. Percutaneous Radiofrequency Ablation for Trigeminal Neuralgia Management: A Randomized, Double-Blinded, Sham-Controlled Clinical Trial // Pain Med. 2023. Vol. 24, № 3. P. 234–243.

. Tuleasca C. et al. Stereotactic radiosurgery for trigeminal neuralgia: a systematic review // J. Neurosurg. 2019. Vol. 130, № 3. P. 733–757.

. Klein J. et al. Peripheral nerve field stimulation for trigeminal neuralgia, trigeminal neuropathic pain, and persistent idiopathic facial pain // Cephalalgia. 2016. Vol. 36, № 5. P. 445–453.

. Gallay M.N., Moser D., Jeanmonod D. MR-Guided Focused Ultrasound Central Lateral Thalamotomy for Trigeminal Neuralgia. Single Center Experience // Front. Neurol. 2020. Vol. 11.

. Urgosik D., Liscak R. Medial Gamma Knife thalamotomy for intractable pain // J. Neurosurg. 2018. Vol. 129, № Suppl1. P. 72–76.

. Zakrzewska J.M., Wu J., Brathwaite T.S.-L. A Systematic Review of the Management of Trigeminal Neuralgia in Patients with Multiple Sclerosis // World Neurosurg. 2018. Vol. 111. P. 291–306.

. Abouharb A., Rathnayake H., Mehta S. The efficacy of surgery over stereotactic radiosurgery in the management of tumor-related trigeminal neuralgia // Chinese Neurosurg. J. 2024. Vol. 10, № 1. P. 27.

. Kim J.H. et al. Pulsed and Conventional Radiofrequency Treatment: Which Is Effective for Dental Procedure-Related Symptomatic Trigeminal Neuralgia? // Pain Med. 2013. Vol. 14, № 3. P. 430–435.

. Peciu-Florianu I. et al. Trigeminal Neuralgia Secondary to Meningiomas and Vestibular Schwannoma Is Improved after Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis // Stereotact. Funct. Neurosurg. 2021. Vol. 99, № 1. P. 6–16.

. Sharav Y. et al. The analgesic effect of amitriptyline on chronic facial pain // Pain. 1987. Vol. 31, № 2. P. 199–209.

. Forssell H. et al. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. // J. Orofac. Pain. 2004. Vol. 18, № 2. P. 131–137.

. Cuadrado M.-L. et al. Botulinum Neurotoxin Type-A for the Treatment of Atypical Odontalgia // Pain Med. 2016. Vol. 17, № 9. P. 1717–1721.

. Liu Y. et al. Burning mouth syndrome: a systematic review of treatments // Oral Dis. 2018. Vol. 24, № 3. P. 325–334.

. McMillan R. et al. Interventions for treating burning mouth syndrome // Cochrane Database Syst. Rev. 2016. Vol. 2016, № 11.

. Lopez-D alessandro E., Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: A randomized, double-blind, placebo controlled trial // Med. Oral Patol. Oral y Cir. Bucal. 2011. P. e635–e640.

. Ta L.E., Dionne R.A. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen // Pain. 2004. Vol. 111, № 1. P. 13–21.

. Ferrillo M. et al. Pain Management and Rehabilitation for Central Sensitization in Temporomandibular Disorders: A Comprehensive Review // Int. J. Mol. Sci. 2022. Vol. 23, № 20. P. 12164.

. Karateev A.E. et al. RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES // Rheumatol. Sci. Pract. 2018. Vol. 56. P. 1–29.

. Castellsague J. et al. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti‐inflammatory drugs in Friuli Venezia Giulia, Italy // Pharmacoepidemiol. Drug Saf. 2013. Vol. 22, № 4. P. 365–375.

. Castellsague J. et al. Individual NSAIDs and Upper Gastrointestinal Complications // Drug Saf. 2012. Vol. 35, № 12. P. 1127–1146.

. Lapeyre‐Mestre M., Grolleau S., Montastruc J. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006 // Fundam. Clin. Pharmacol. 2013. Vol. 27, № 2. P. 223–230.

. Kimos P. et al. Analgesic action of gabapentin on chronic pain in the masticatory muscles: A randomized controlled trial // Pain. 2007. Vol. 127, № 1. P. 151–160.

. Abboud W.A. et al. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections // Int. J. Oral Maxillofac. Surg. 2017. Vol. 46, № 11. P. 1417–1423.

. Patel J., Cardoso J.A., Mehta S. A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism // Br. Dent. J. 2019. Vol. 226, № 9. P. 667–672.

. Thambar S. et al. Botulinum toxin in the management of temporomandibular disorders: a systematic review // Br. J. Oral Maxillofac. Surg. 2020. Vol. 58, № 5. P. 508–519.

. Harrison S. et al. A comparison of antidepressant medication alone and in conjunction with cognitive behavioural therapy for chronic idiopathic facial pain. 1997. 663–672 p.

. Bergdahl J., Anneroth G., Ferris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study // J. Oral Pathol. Med. 1995. Vol. 24, № 5. P. 213–215.

. Miziara I.D. et al. Group psychotherapy: An additional approach to burning mouth syndrome // J. Psychosom. Res. 2009. Vol. 67, № 5. P. 443–448.

. Florjanski W. et al. Evaluation of Biofeedback Usefulness in Masticatory Muscle Activity Management—A Systematic Review // J. Clin. Med. 2019. Vol. 8, № 6. P. 766.

. Barker S., Urbanek M., Penlington C. Psychological Interventions for Persistent Orofacial Pain // Prim. Dent. J. 2018. Vol. 7, № 4. P. 30–34.

. Bayer E. et al. Sphenopalatine Ganglion Pulsed Radiofrequency Treatment in 30 Patients Suffering from Chronic Face and Head Pain // Pain Pract. 2005. Vol. 5, № 3. P. 223–227.

. Wiffen P.J. et al. Gabapentin for chronic neuropathic pain in adults // Cochrane Database Syst. Rev. 2017. Vol. 2020, № 2.

. Derry S. et al. Pregabalin for neuropathic pain in adults // Cochrane Database Syst. Rev. 2019.

. Bockbrader H.N. et al. A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin // Clin. Pharmacokinet. 2010. Vol. 49, № 10. P. 661–669.

. Patel R., Dickenson A.H. Mechanisms of the gabapentinoids and α 2 δ ‐1 calcium channel subunit in neuropathic pain // Pharmacol. Res. Perspect. 2016. Vol. 4, № 2.

. Zhou M. et al. Oxcarbazepine for neuropathic pain // Cochrane Database Syst. Rev. 2017. Vol. 2017, № 12.

. Urquhart D.M. et al. Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain // JAMA Intern. Med. 2018. Vol. 178, № 11. P. 1474.

. Moore R.A. et al. Amitriptyline for neuropathic pain in adults // Cochrane Database Syst. Rev. 2015. Vol. 2019, № 5.

. Aiyer R., Barkin R.L., Bhatia A. Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review // Pain Med. 2016. P. pnw261.

. Finnerup N.B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis // Lancet Neurol. 2015. Vol. 14, № 2. P. 162–173.

. Baron R., Mahn F. Topische Therapieformen bei peripheren neuropathischen Schmerzen // Der Schmerz. 2010. Vol. 24, № 4. P. 317–325.

. Derry S. et al. Topical lidocaine for neuropathic pain in adults // Cochrane Database of Systematic Reviews / ed. Derry S. Chichester, UK: John Wiley & Sons, Ltd, 2014.

. Freo U., Romualdi P., Kress H.G. Tapentadol for neuropathic pain: a review of clinical studies // J. Pain Res. 2019. Vol. Volume 12. P. 1537–1551.

. Atkinson T.J. et al. Medication Pain Management in the Elderly: Unique and Underutilized Analgesic Treatment Options // Clin. Ther. 2013. Vol. 35, № 11. P. 1669–1689.

. Gaskell H. et al. Oxycodone for neuropathic pain in adults // Cochrane Database Syst. Rev. 2016. Vol. 2016, № 7.

. Duehmke R.M. et al. Tramadol for neuropathic pain in adults // Cochrane Database Syst. Rev. 2017. Vol. 2017, № 6.

. Cooper T.E. et al. Morphine for chronic neuropathic pain in adults // Cochrane Database Syst. Rev. 2017. Vol. 2019, № 5.

. Nucynta E.R. (tapentadol HCl) [package insert]. http://www.ac cessdata.fda.gov/drugsatfda_ docs/label/2012/200533s001lbl. pdf. Accessed August 14, 2013 [Electronic resource].

. Viana M.D.M. et al. Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain. // Antioxidants (Basel, Switzerland). 2022. Vol. 11, № 12.

. Priyank H. et al. Management protocols of chronic Orofacial Pain: A Systematic Review // Saudi Dent. J. 2023. Vol. 35, № 5. P. 395–402.

. Dekhne A. et al. Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review // Cureus. 2023.

. Park J., Park H. Botulinum Toxin for the Treatment of Neuropathic Pain // Toxins (Basel). 2017. Vol. 9, № 9. P. 260.

. Carneiro B.D., Tavares I. Transcranial Magnetic Stimulation to Treat Neuropathic Pain: A Bibliometric Analysis // Healthcare. 2024. Vol. 12, № 5. P. 555.

. Baron R., Wasner G. Prevention and treatment of postherpetic neuralgia // Lancet. 2006. Vol. 367, № 9506. P. 186–188.

. Peng Z. et al. Effect of hyperbaric oxygen therapy on patients with herpes zoster. // Undersea Hyperb. Med. 2012. Vol. 39, № 6. P. 1083–1087.

. Schiavo S. et al. Mechanistic Rationale and Clinical Efficacy of Hyperbaric Oxygen Therapy in Chronic Neuropathic Pain: An Evidence-Based Narrative Review // Pain Res. Manag. 2021. Vol. 2021. P. 1–20.

. Chan A.S. et al. Phase II study of alpha‐tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis // Cancer. 2004. Vol. 100, № 2. P. 398–404.

. Chung C., Bryant A., Brown P.D. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery // Cochrane Database Syst. Rev. 2018. Vol. 2018, № 7.

. Gothard L. et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy // Radiother. Oncol. 2005. Vol. 75, № 3. P. 334–341.

. Arqueros-Lemus M. et al. Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review // Med. Oral Patol. Oral y Cir. Bucal. 2023. P. e293–e300.

. Co J. et al. Hyperbaric Oxygen for Radiation Necrosis of the Brain // Can. J. Neurol. Sci. / J. Can. des Sci. Neurol. 2020. Vol. 47, № 1. P. 92–99.

. Bernhardt D. et al. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment // Strahlentherapie und Onkol. 2022. Vol. 198, № 11. P. 971–980.

. Brown J.A., Pilitsis J.G. Motor Cortex Stimulation for Central and Neuropathic Facial Pain: A Prospective Study of 10 Patients and Observations of Enhanced Sensory and Motor Function during Stimulation // Neurosurgery. 2005. Vol. 56, № 2. P. 290–297.

. Rasche D., Tronnier V.M. Clinical Significance of Invasive Motor Cortex Stimulation for Trigeminal Facial Neuropathic Pain Syndromes // Neurosurgery. 2016. Vol. 79, № 5. P. 655–666.

. Kolodziej M. et al. Treatment of Central Deafferentation and Trigeminal Neuropathic Pain by Motor Cortex Stimulation: Report of a Series of 20 Patients // J. Neurol. Surg. Part A Cent. Eur. Neurosurg. 2015. Vol. 77, № 01. P. 052–058.

. Li H. et al. Effective Treatment of Postherpetic Neuralgia at the First Branch of the Trigeminal Nerve by High-Voltage Pulsed Radiofrequency // Front. Neurol. 2021. Vol. 12.

. Zhang H. et al. Supraorbital Nerve Radiofrequency for Severe Neuralgia Caused by Herpes Zoster Ophthalmicus // Pain Res. Manag. 2020. Vol. 2020. P. 1–7.

. Johnson M.D., Burchiel K.J. Peripheral stimulation for treatment of trigeminal postherpetic neuralgia and trigeminal posttraumatic neuropathic pain: a pilot study. // Neurosurgery. 2004. Vol. 55, № 1. P. 135–141; discussion 141-2.

. Texakalidis P. et al. Peripheral trigeminal branch stimulation for refractory facial pain: A single-center experience // Clin. Neurol. Neurosurg. 2020. Vol. 194. P. 105819.

. Ellis J.A., Mejia Munne J.C., Winfree C.J. Trigeminal branch stimulation for the treatment of intractable craniofacial pain // J. Neurosurg. 2015. Vol. 123, № 1. P. 283–288.

. William A. et al. Trigeminal and sphenopalatine ganglion stimulation for intractable craniofacial pain—case series and literature review // Acta Neurochir. (Wien). 2016. Vol. 158, № 3. P. 513–520.

. Slavin K. V. et al. Trigeminal and occipital peripheral nerve stimulation for craniofacial pain: a single-institution experience and review of the literature // Neurosurg. Focus. 2006. Vol. 21, № 6. P. 1–5.

. Anisimov E.D. et al. Open and Percutaneous Trigeminal Nucleotractotomy: A Case Series and Literature Review // Stereotact. Funct. Neurosurg. 2023. Vol. 101, № 6. P. 387–394.

. Chivukula S. et al. Spinal and Nucleus Caudalis Dorsal Root Entry Zone Lesioning for Chronic Pain: Efficacy and Outcomes // World Neurosurg. 2015. Vol. 84, № 2. P. 494–504.

. Kanpolat Y. et al. SPINAL AND NUCLEUS CAUDALIS DORSAL ROOT ENTRY ZONE OPERATIONS FOR CHRONIC PAIN // Oper. Neurosurg. 2008. Vol. 62, № 3. P. 235–244.

. Cohen A.S., Burns B., Goadsby P.J. High-Flow Oxygen for Treatment of Cluster Headache // JAMA. 2009. Vol. 302, № 22. P. 2451.

. Medrea I. et al. Network meta‐analysis of therapies for cluster headache: Effects of acute therapies for episodic and chronic cluster // Headache J. Head Face Pain. 2022. Vol. 62, № 4. P. 482–511.

. Oude Nijhuis J.C., Haane D.Y., Koehler P.J. A review of the current and potential oxygen delivery systems and techniques utilized in cluster headache attacks // Cephalalgia. 2016. Vol. 36, № 10. P. 970–979.

. Petersen A.S. et al. Oxygen therapy for cluster headache. A mask comparison trial. A single-blinded, placebo-controlled, crossover study // Cephalalgia. 2017. Vol. 37, № 3. P. 214–224.

. Evers S., Rapoport A. The use of oxygen in cluster headache treatment worldwide – a survey of the International Headache Society (IHS) // Cephalalgia. 2017. Vol. 37, № 4. P. 396–398.

. Fogan L. Treatment of Cluster Headache // Arch. Neurol. 1985. Vol. 42, № 4. P. 362.

. Kudrow L. Response of Cluster Headache Attacks to Oxygen Inhalation // Headache J. Head Face Pain. 1981. Vol. 21, № 1. P. 1–4.

. May A. et al. European Academy of Neurology guidelines on the treatment of cluster headache // Eur. J. Neurol. 2023. Vol. 30, № 10. P. 2955–2979.

. Law S., Derry S., Moore R.A. Triptans for acute cluster headache // Cochrane Database Syst. Rev. 2013. Vol. 2018, № 5.

. Cittadini E. et al. Effectiveness of Intranasal Zolmitriptan in Acute Cluster Headache // Arch. Neurol. 2006. Vol. 63, № 11. P. 1537.

. Robbins L. Intranasal Lidocaine for Cluster Headache // Headache J. Head Face Pain. 1995. Vol. 35, № 2. P. 83–84.

. Barzegari H. et al. Intranasal Lidocaine for Primary Headache Management in Emergency Department; a Clinical Trial. // Emerg. (Tehran, Iran). 2017. Vol. 5, № 1. P. e79.

. Petersen A.S. et al. Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives // Headache J. Head Face Pain. 2019. Vol. 59, № 8. P. 1198–1211.

. Leone M. et al. Verapamil in the prophylaxis of episodic cluster headache: A double-blind study versus placebo // Neurology. 2000. Vol. 54, № 6. P. 1382–1385.

. Bussone G. et al. Double Blind Comparison of Lithium and Verapamil in Cluster Headache Prophylaxis // Headache J. Head Face Pain. 1990. Vol. 30, № 7. P. 411–417.

. Obermann M. et al. Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial // Lancet Neurol. 2021. Vol. 20, № 1. P. 29–37.

. Steiner T. et al. Double-Blind Placebo-Controlled Trial of Lithium in Episodic Cluster Headache // Cephalalgia. 1997. Vol. 17, № 6. P. 673–675.

. Leone M. et al. Melatonin Versus Placebo in the Prophylaxis of Cluster Headache // Cephalalgia. 1996. Vol. 16, № 7. P. 494–496.

. Pringsheim T. et al. Melatonin as Adjunctive Therapy in the Prophylaxis of Cluster Headache: A Pilot Study // Headache J. Head Face Pain. 2002. Vol. 42, № 8. P. 787–792.

. Huang W. et al. Topiramate in prevention of cluster headache in the Taiwanese // Neurol. India. 2010. Vol. 58, № 2. P. 284.

. Leone M. et al. Topiramate in Cluster Headache Prophylaxis: an Open Trial // Cephalalgia. 2003. Vol. 23, № 10. P. 1001–1002.

. Ambrosini A. et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: A double-blind placebo-controlled study // Pain. 2005. Vol. 118, № 1. P. 92–96.

. Leroux E. et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial // Lancet Neurol. 2011. Vol. 10, № 10. P. 891–897.

. Busch V. et al. Occipital Nerve Blockade in Chronic Cluster Headache Patients and Functional Connectivity Between Trigeminal and Occipital Nerves // Cephalalgia. 2007. Vol. 27, № 11. P. 1206–1214.

. Costa A. et al. The Effect of Intranasal Cocaine and Lidocaine on Nitroglycerin‐Induced Attacks in Cluster Headache // Cephalalgia. 2000. Vol. 20, № 2. P. 85–91.

. Sanders M., Zuurmond W.W.A. Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headache: a 12- to 70-month follow-up evaluation // J. Neurosurg. 1997. Vol. 87, № 6. P. 876–880.

. Fang L. et al. Computerized tomography-guided sphenopalatine ganglion pulsed radiofrequency treatment in 16 patients with refractory cluster headaches: Twelve- to 30-month follow-up evaluations // Cephalalgia. 2016. Vol. 36, № 2. P. 106–112.

. Narouze S. et al. Sphenopalatine Ganglion Radiofrequency Ablation for the Management of Chronic Cluster Headache // Headache J. Head Face Pain. 2009. Vol. 49, № 4. P. 571–577.

. Bendersky D.C., Hem S.M., Yampolsky C.G. Unsuccessful Pulsed Radiofrequency of the Sphenopalatine Ganglion in Patients with Chronic Cluster Headache and Subsequent Successful Thermocoagulation // Pain Pract. 2015. Vol. 15, № 5.

. Miller S., Watkins L., Matharu M. Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients // Eur. J. Neurol. 2017. Vol. 24, № 2. P. 381–390.

. Leone M. et al. Long-term occipital nerve stimulation for drug-resistant chronic cluster headache // Cephalalgia. 2017. Vol. 37, № 8. P. 756–763.

. Fontaine D. et al. Occipital nerve stimulation improves the quality of life in medically-intractable chronic cluster headache: Results of an observational prospective study // Cephalalgia. 2017. Vol. 37, № 12. P. 1173–1179.

. Dzhafarov V.M. et al. Sphenopalatine ganglion stimulation in the treatment of chronic refractory cluster headache. A preliminary multicenter study in Russia // Zhurnal Nevrol. i psikhiatrii im. S.S. Korsakova. 2022. Vol. 122, № 2. P. 68.

. Schoenen J. et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study // Cephalalgia. 2013. Vol. 33, № 10. P. 816–830.

. Goadsby P.J. et al. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial // Lancet Neurol. 2019. Vol. 18, № 12. P. 1081–1090.

. Barloese M. et al. Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry // J. Headache Pain. 2018. Vol. 19, № 1. P. 6.

. Pareja J.A., Sjaastad O. Chronic Paroxysmal Hemicrania and Hemicrania Continua. Interval Between Indomethacin Administration and Response // Headache J. Head Face Pain. 1996. Vol. 36, № 1. P. 20–23.

. Baraldi C. et al. Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal // J. Headache Pain. 2017. Vol. 18, № 1. P. 71.

. D’Andrea G. et al. Lamotrigine in the treatment of SUNCT syndrome // Neurology. 2001. Vol. 57, № 9. P. 1723–1725.

. Gutierrez‐Garcia J.M. SUNCT Syndrome Responsive to Lamotrigine // Headache J. Head Face Pain. 2002. Vol. 42, № 8. P. 823–825.

. Graff-Radford S. SUNCT Syndrome Responsive to Gabapentin (Neurontin) // Cephalalgia. 2000. Vol. 20, № 5. P. 515–517.

. Etemadifar M. et al. Efficacy of Gabapentin in the Treatment of SUNCT Syndrome // Cephalalgia. 2008. Vol. 28, № 12. P. 1339–1342.

. Kang M.-K., Cho S.-J. SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update. // Cephalalgia. 2024. Vol. 44, № 2. P. 3331024241232256.

. Matharu M., Cohen A., Goadsby P. SUNCT Syndrome Responsive to Intravenous Lidocaine // Cephalalgia. 2004. Vol. 24, № 11. P. 985–992.

. Arroyo A.M. et al. Response to Intravenous Lidocaine in a Patient with SUNCT Syndrome // Cephalalgia. 2010. Vol. 30, № 1. P. 110–112.

. Пархоменко Е.В. et al. SUNCT-синдром. От клинической диагностики к возможности эффективной терапии // Медицинский алфавит. 2017. Vol. 1, № 2. P. 33–40.

. Cittadini E., Goadsby P.J. Hemicrania continua: a clinical study of 39 patients with diagnostic implications // Brain. 2010. Vol. 133, № 7. P. 1973–1986.

. Ramsey M.J. et al. Corticosteroid Treatment for Idiopathic Facial Nerve Paralysis: A Meta‐analysis // Laryngoscope. 2000. Vol. 110, № 3. P. 335–341.

. Abdu S.H. et al. Comparison of oral versus intravenous steroid in the management of Bell’s palsy: a systematic review and meta-analysis of randomized clinical trials // Eur. Arch. Oto-Rhino-Laryngology. 2024. Vol. 281, № 3. P. 1095–1104.

. Madhok V.B. et al. Corticosteroids for Bell’s palsy (idiopathic facial paralysis) // Cochrane Database Syst. Rev. 2016. Vol. 2016, № 7.

. Zavaliy L.B. et al. Treatment of patients with facial neuropathy by practicing neurologists: online survey // Russ. Neurol. J. 2023. Vol. 28, № 3. P. 28–35.

. Giri P. et al. Single dose intravenous methyl prednisolone versus oral prednisolone in Bell’s palsy: a randomized controlled trial. // Indian J. Pharmacol. 2015. Vol. 47, № 2. P. 143–147.

. Kumar S, Anwar K, Kumar J. Comparative study of administration of single dose intravenous methyl prednisolone versus oral prednisolone in Bell’s palsy: an open labeled, randomized controlled trial // Int. J. Med. Heal. Res. 2021. Vol. 13. P. 138–143.

. Verma S et al. Treatment of Bell’s palsy: comparing the administration of a single dose intravenous methyl prednisolone vs oral prednisolone: an open labeled, randomized controlled trial // Int. J. Med. Heal. Res. 2021. Vol. 13. P. 287–292.

. Fujiwara T. et al. Intratympanic corticosteroid for Bell’s palsy and Ramsay Hunt syndrome: Systematic review and meta-analysis // Auris Nasus Larynx. 2022. Vol. 49, № 4. P. 599–605.

. Gagyor I. et al. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis) // Cochrane Database Syst. Rev. 2019. Vol. 2019, № 9.

. Fu X. et al. A Network Meta-Analysis to Compare the Efficacy of Steroid and Antiviral Medications for Facial Paralysis from Bell´s Palsy. // Pain Physician. 2018. Vol. 21, № 6. P. 559–569.

. Quant E.C. et al. The benefits of steroids versus steroids plus antivirals for treatment of Bell’s palsy: a meta-analysis // BMJ. 2009. Vol. 339, № sep07 1. P. b3354–b3354.

. Sullivan F.M. et al. Early Treatment with Prednisolone or Acyclovir in Bell’s Palsy // N. Engl. J. Med. 2007. Vol. 357, № 16. P. 1598–1607.

. Sullivan F. et al. A randomised controlled trial of the use of aciclovir and/or prednisolone for the early treatment of Bell’s palsy: the BELLS study // Health Technol. Assess. (Rockv). 2009. Vol. 13, № 47.

. Engström M. et al. Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial // Lancet Neurol. 2008. Vol. 7, № 11. P. 993–1000.

. de Almeida J.R. et al. Combined Corticosteroid and Antiviral Treatment for Bell Palsy // JAMA. 2009. Vol. 302, № 9. P. 985.

. Fujiwara T., Uraguchi K. Antiviral treatment for Ramsay Hunt syndrome: A systematic review and meta-analysis // Auris Nasus Larynx. 2024. Vol. 51, № 3. P. 488–491.

. Sanchez E. et al. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis // JAMA. 2016. Vol. 315, № 16. P. 1767.

. Скрипченко Н.В., Голяков Д.А., Пульман Н.Ф. Невропатии лицевого нерва: клинические особенности и возможности улучшения исходов // Детские инфекции. 2008. Vol. 7, № 3. P. 16–23.

. Eccleston C. et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents // Cochrane Database Syst. Rev. 2017.

. Свистушкин В.М., Славский А.Н. Невропатия лицевого нерва: современные подходы к диагностике и лечению // РМЖ. 2016. Vol. 24, № 4. P. 280–285.

. Соловьева Э.Ю. et al. Клинические рекомендации по применению нейротропных витаминов группы В (В1, В6 и В12) для лечения периферической невропатии: консенсус многопрофильной экспертной группы // Нервные болезни. 2024. Vol. 1. P. 91–98.

. Orlova O.R. et al. Botulinum therapy for facial nerve disorders in Russia // Russ. Neurol. J. 2024. Vol. 28, № 6. P. 34–40.

. Саксонова Е.В., Орлова О.Р., Суровых С.В. Восстановление симметрии лица с помощью ботулинического токсина типа А // Метаморфозы. 2015. Vol. 10.

. Zavaliy L.B. et al. Botulinum Therapy in Facial Nerve Neuropathy // Russ. Neurol. J. 2020. Vol. 25, № 1. P. 23–28.

. Akulov M. et al. Long-Term Effectiveness of Botulinum Toxin Therapy for Facial Nerve Neuropathy After Neurosurgical Interventions // Toxicon. 2024. Vol. 237. P. 107354.

. Орлова О.Р. et al. Коррекция синкинезий ботулиническим нейропротеином типа А // Фарматека. 2019. Vol. 13. P. 37–41.

. Akulov M.A. et al. Botulinum toxin type A in the treatment of synkinesis: a clinical case report and literature review // Vestn. Nevrol. Psihiatr. i Nejrohir. (Bulletin Neurol. Psychiatry Neurosurgery). 2024. № 5. P. 562–570.

. de Jongh F.W. et al. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis // Eur. Arch. Oto-Rhino-Laryngology. 2023. Vol. 280, № 4. P. 1581–1592.

. Wei L.A., Diels J., Lucarelli M.J. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis // Ophthalmic Plast. Reconstr. Surg. 2016. Vol. 32, № 2. P. 138–141.

. Patel P.N. et al. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis // JAMA Facial Plast. Surg. 2018. Vol. 20, № 3. P. 196–201.

. Hetzler L.T. et al. Anatomic Considerations of Perinasal Musculature for Improved Dental Show During Smile in Facial Synkinesis // Facial Plast. Surg. Aesthetic Med. 2022. Vol. 24, № 2. P. 89–94.

. Lindsay R.W. et al. A systematic algorithm for the management of lower lip asymmetry // Am. J. Otolaryngol. 2011. Vol. 32, № 1. P. 1–7.

. Joseph S.S. et al. Evaluation of Patients with Facial Palsy and Ophthalmic Sequelae: A 23-Year Retrospective Review // Ophthalmic Epidemiol. 2017. Vol. 24, № 5. P. 341–345.

. MacIntosh P.W., Fay A.M. Update on the ophthalmic management of facial paralysis // Surv. Ophthalmol. 2019. Vol. 64, № 1. P. 79–89.

. Kasatkin D.S. et al. Clinico-diagnostic and pathophysiological grounds of conservative and early surgical treatment methods of Bell palsy in the acute period // Russ. Neurol. J. 2021. Vol. 26, № 2. P. 4–10.

. Steinhäuser J. et al. Multidisciplinary Care of Patients with Facial Palsy: Treatment of 1220 Patients in a German Facial Nerve Center // J. Clin. Med. 2022. Vol. 11, № 2. P. 427.

. Bodénez C. et al. Facial nerve decompression for idiopathic Bell’s palsy: report of 13 cases and literature review // J. Laryngol. Otol. 2010. Vol. 124, № 3. P. 272–278.

. McAllister K. et al. Surgical interventions for the early management of Bell’s palsy // Cochrane Database Syst. Rev. 2013.

. Неробеев А.И. Восстановительная хирургия мягких тканей челюстно-лицевой области / ed. Неробеев А.И., Плотников Н.А. Москва: Медицина, 1997. 200 p.

. Scaramella L.F. Cross-face facial nerve anastomosis: historical notes. // Ear. Nose. Throat J. 1996. Vol. 75, № 6. P. 343, 347–352, 354.

. Peng G., Azizzadeh B. Cross-Facial Nerve Grafting for Facial Reanimation // Facial Plast. Surg. 2015. Vol. 31, № 02. P. 128–133.

. Hayashi A. et al. Assessment of T-shape double fascia graft for lower lip deformity from facial paralysis: A questionnaire survey // J. Plast. Reconstr. Aesthetic Surg. 2016. Vol. 69, № 3. P. 427–435.

. Cabin J.A., Massry G.G., Azizzadeh B. Botulinum toxin in the management of facial paralysis // Curr. Opin. Otolaryngol. Head Neck Surg. 2015. Vol. 23, № 4. P. 272–280.

. Chi J.J. Management of the Eye in Facial Paralysis // Facial Plast. Surg. Clin. North Am. 2016. Vol. 24, № 1. P. 21–28.

. Chopade T.R., Lui F., Bollu P.C. Hemifacial Spasm. 2024.

. Green K.E., Rastall D., Eggenberger E. Treatment of Blepharospasm/Hemifacial Spasm // Curr. Treat. Options Neurol. 2017. Vol. 19, № 11. P. 41.

. Kemp L.W., Reich S.G. Hemifacial spasm // Curr. Treat. Options Neurol. 2004. Vol. 6, № 3. P. 175–179.

. Xiao L. et al. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry // J. Neurol. 2018. Vol. 265, № 9. P. 2097–2105.

. Kongsaengdao S., Maneeton N., Maneeton B. The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A // Toxins (Basel). 2021. Vol. 13, № 3. P. 215.

. Jitpimolmard S. et al. A Double-Blind, Placebo-Controlled Study of Appropriate Site of Botulinum Toxin Therapy in Hemifacial Spasm // Adv. Ther. 2022. Vol. 39, № 5. P. 2025–2034.

. Akulov M.A. et al. Higher efficacy of botulinum toxin therapy for hemifacial spasm recurrence after vascular decompression. Case report and literature review // Vopr. neirokhirurgii Im. N.N. Burdenko. 2022. Vol. 86, № 2. P. 89.

. Akulov M.A. et al. Experience in treating hemifacial spasm combined with facial nerve neuropathy. A clinical case report // Vestn. Nevrol. Psihiatr. i Nejrohir. (Bulletin Neurol. Psychiatry Neurosurgery). 2024. № 3. P. 351–357.

. Thirumala P.D. et al. The Utility of Intraoperative Lateral Spread Recording in Microvascular Decompression for Hemifacial Spasm: A Systematic Review and Meta-Analysis // Neurosurgery. 2020. Vol. 87, № 4. P. E473–E484.

. Fraioli M. et al. Treatment of Idiopathic Hemifacial Spasm with Radiosurgery or Hypofractionated Stereotactic Radiotherapy: Preliminary Results // min - Minim. Invasive Neurosurg. 2010. Vol. 53, № 01. P. 34–36.

. Park J.S., Ahn Y.H. Glossopharyngeal Neuralgia. // J. Korean Neurosurg. Soc. 2023. Vol. 66, № 1. P. 12–23.

. Luef G., Poewe W. Oxcarbazepine in glossopharyngeal neuralgia: Clinical response and effect on serum lipids // Neurology. 2004. Vol. 63, № 12. P. 2447–2448.

. Hamilton K.T. et al. Refractory glossopharyngeal neuralgia successfully treated with onabotulinumtoxinA: A case report // Headache J. Head Face Pain. 2022. Vol. 62, № 10. P. 1424–1428.

. You S. et al. Long-Term Follow-Up of Ultrasound-Guided Glossopharyngeal Nerve Block Treatment for Glossopharyngeal Neuralgia: A Retrospective Clinical Study of 43 Cases // J. Pain Res. 2024. Vol. Volume 17. P. 913–921.

. Liu Q. et al. Ultrasound-guided glossopharyngeal nerve block via the styloid process for glossopharyngeal neuralgia: a retrospective study // J. Pain Res. 2019. Vol. Volume 12. P. 2503–2510.

. Xia L. et al. Microvascular decompression for glossopharyngeal neuralgia: a retrospective analysis of 228 cases // Acta Neurochir. (Wien). 2018. Vol. 160, № 1. P. 117–123.

. Revuelta-Gutiérrez R. et al. Microvascular decompression for glossopharyngeal neuralgia through a microasterional approach: A case series // Surg. Neurol. Int. 2016. Vol. 7, № 1. P. 51.

. Zheng X. et al. Microvascular Decompression Alone without Rhizotomy Is an Effective Way of Treating Glossopharyngeal Neuralgia: Clinical Analysis of 46 Cases // Stereotact. Funct. Neurosurg. 2020. Vol. 98, № 2. P. 129–135.

. Siempis T. et al. Stereotactic radiosurgery for idiopathic glossopharyngeal neuralgia: A systematic review // World Neurosurg. X. 2024. Vol. 22. P. 100325.

. Ma Y. et al. Neurosurgical treatment of glossopharyngeal neuralgia: analysis of 103 cases // J. Neurosurg. 2016. Vol. 124, № 4. P. 1088–1092.

. Zavaliy L.B. et al. Neuropsychological Principles of Rehabilitation Training in the Therapy of Patients with Facial Nerve Palsy // Russ. Sklifosovsky J. “Emergency Med. Care.” 2022. Vol. 11, № 3. P. 457–463.

. Nakano H. et al. Physical therapy for peripheral facial palsy: A systematic review and meta-analysis // Auris Nasus Larynx. 2024. Vol. 51, № 1. P. 154–160.

. Khan A.J. et al. Physical therapy for facial nerve paralysis (Bell’s palsy): An updated and extended systematic review of the evidence for facial exercise therapy // Clin. Rehabil. 2022. Vol. 36, № 11. P. 1424–1449.

. Di Stadio A. et al. Facial taping as biofeedback to improve the outcomes of physical rehab in Bell’s palsy: preliminary results of a randomized case–control study // Eur. Arch. Oto-Rhino-Laryngology. 2021. Vol. 278, № 5. P. 1693–1698.

. VanSwearingen J.M., Brach J.S. Validation of a Treatment-Based Classification System for Individuals With Facial Neuromotor Disorders // Phys. Ther. 1998. Vol. 78, № 7. P. 678–689.

. Lindsay R.W., Robinson M., Hadlock T.A. Comprehensive Facial Rehabilitation Improves Function in People With Facial Paralysis: A 5-Year Experience at the Massachusetts Eye and Ear Infirmary // Phys. Ther. 2010. Vol. 90, № 3. P. 391–397.

. Kim J.-H. et al. The Effects of Symmetrical Self-performed Facial Muscle Exercises on the Neuromuscular Facilitation of Patients with Facial Palsy // J. Phys. Ther. Sci. 2011. Vol. 23, № 4. P. 543–547.

. Castaldo M. et al. The Use of Mirror Therapy in Peripheral Seventh Nerve Palsy: A Systematic Review // Brain Sci. 2024. Vol. 14, № 6. P. 530.

. Volk G.F. et al. Effect of an Intensified Combined Electromyography and Visual Feedback Training on Facial Grading in Patients With Post-paralytic Facial Synkinesis // Front. Rehabil. Sci. 2021. Vol. 2.

. Santiago S. et al. Effectiveness of novel facial stretching with structured exercise versus conventional exercise for Bell’s palsy: a single-blinded randomized clinical trial // Sci. Rep. 2024. Vol. 14, № 1. P. 13266.

. MORISHIMA N. et al. Effect of muscle strengthening on peripheral facial palsy: A randomized controlled trial // Phys. Ther. Res. 2020. Vol. 23, № 1. P. 59–65.

. Dimitrova A., Murchison C., Oken B. Acupuncture for the Treatment of Peripheral Neuropathy: A Systematic Review and Meta-Analysis // J. Altern. Complement. Med. 2017. Vol. 23, № 3. P. 164–179.

. Zhang R. et al. Compare the efficacy of acupuncture with drugs in the treatment of Bell’s palsy // Medicine (Baltimore). 2019. Vol. 98, № 19. P. e15566.

. Li P., Qiu T., Qin C. Efficacy of Acupuncture for Bell’s Palsy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials // PLoS One. 2015. Vol. 10, № 5. P. e0121880.

. Zou Z. Comparison of Efficacy and Safety of Acupuncture and Moxibustion in Acute Phase and Non-acute Phase of Bell’s Palsy: a meta-analysis. // Neuro Endocrinol. Lett. 2021. Vol. 42, № 7. P. 438–445.

. van Landingham S.W., Diels J., Lucarelli M.J. Physical therapy for facial nerve palsy // Curr. Opin. Ophthalmol. 2018. Vol. 29, № 5. P. 469–475.

. Holland N.J., Bernstein J.M., Hamilton J.W. Hyperbaric oxygen therapy for Bell’s palsy // Cochrane Database Syst. Rev. 2012. Vol. 2016, № 7.

. Racic G. et al. Hyperbaric oxygen as a therapy of Bell’s palsy. // Undersea Hyperb. Med. 1997. Vol. 24, № 1. P. 35–38.

. Ordahan B., Karahan A. yavuz. Role of low-level laser therapy added to facial expression exercises in patients with idiopathic facial (Bell’s) palsy // Lasers Med. Sci. 2017. Vol. 32, № 4. P. 931–936.

. Alayat M.S.M., Elsodany A.M., El Fiky A.A.R. Efficacy of high and low level laser therapy in the treatment of Bell’s palsy: A randomized double blind placebo-controlled trial // Lasers Med. Sci. 2014. Vol. 29, № 1. P. 335–342.

. Ton G. et al. Effects of Laser Acupuncture Therapy for Patients With Inadequate Recovery From Bell’s Palsy: Preliminary Results From Randomized, Double-Blind, Sham-Controlled Study // J. Lasers Med. Sci. 2021. Vol. 12, № 1. P. e70–e70.

. Ferrari M. et al. Oxford Textbook of Headache Syndromes. Oxford University Press, 2020.

. Завалий Л.Б. Памятка для пациента с невропатией лицевого нерва // Нервные болезни. 2024. Vol. 2. P. 68–74.

. Bouhassira D. et al. Development and validation of the Neuropathic Pain Symptom Inventory // Pain. 2004. Vol. 108, № 3. P. 248–257.

. Freynhagen R. et al. pain DETECT : a new screening questionnaire to identify neuropathic components in patients with back pain // Curr. Med. Res. Opin. 2006. Vol. 22, № 10. P. 1911–1920.

. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs // Pain. 2001. Vol. 92, № 1. P. 147–157.

. Юсупова Д.Г. et al. Валидация Лидской шкалы оценки нейропатической боли (LANSS) в России // Нервно-мышечные болезни. 2018. Vol. 8, № 3. P. 43–50.

. Ross B.G., Fradet G., Nedzelski J.M. Development of a Sensitive Clinical Facial Grading System // Otolaryngol. Neck Surg. 1996. Vol. 114, № 3. P. 380–386.